Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction 
Company name: Novartis Animal Health UK Ltd
Address: Frimley Business Park
Frimley
Camberley
Surrey
GU16 7SR
Telephone: 01276 694402
Fax: 01276 694403
Presentation
White to light yellow, round, biconvex tablets, with bevelled edges.
Capstar 11.4mg tablets:11.4mg nitenpyram imprinted on one side with ''RB'', on the other side with ''CG''.
Capstar 57mg tablets: 57mg nitenpyram imprinted on one side with ''HIH'', on the other side with CG''.
Uses
Capstar is indicated for the treatment of fleas on dogs and cats.
Dosage and administration
Capstar tablets are administered orally at a minimum recommended dose of 1mg/kg, with the following recommendations:
Weight of cat or dog
| Dose
| 1 – 11kg
| 1 tablet CAPSTAR 11.4mg
| 11.1 – 57kg
| 1 tablet CAPSTAR 57mg
| Over 57kg
| 2 tablets CAPSTAR 57mg
|
Capstar tablets should be given orally, either directly into the mouth or mixed into a small portion of food and given immediately. Administer on any day when fleas are seen on the animal. No more than one treatment should be given per day.
Contra-indications
None.
Special precautions for use
Do not use on animals less than 4 weeks old or weighing less than 1kg.
Undesirable effects
For the first hour after administration, the pet may scratch more than normal. This effect is caused by the fleas reacting to the product.
Pharmaceutical precautions
Keep out of reach and sight of children.
Do not store above 25°C.
Do not use the tablets after their expiry date.
Legal category
AVM-GSL
Packaging Quantities
Aluminium blister containing 6 tablets. Cardboard box containing 1 blister.
Further information
Effects on fleas may be seen as soon as 15 minutes after administration. Between 95% and 100% efficacy is observed within the first 6 hours and 100% efficacy is reached within 24 hours.
To help prevent re-infestation, the additional use of a suitable treatment to control immature stages of the flea life cycle in the environment is recommended. If in doubt consult your veterinary surgeon.
Nitenpyram is neither embryotoxic nor teratogenic. It can be given to animals at all stages of pregnancy or lactation.
No adverse drug reactions were seen when nitenpyram was administered with other products commonly used in small animal veterinary practice including commonly used flea products, vaccines or antibiotics.
Overdose: nitenpyram is well tolerated. Overdosage up to 70mg/kg was asymptomatic.
Marketing authorisation numbers
Capstar 11.4 mg Vm 12501/4059
Capstar 57 mg Vm 12501/4060
| 
